The objectives of this study were to determine the sequence of events leading to ERBB2 degradation upon HSP90 inhibition, to understand the mechanism of action of potentially useful anti-cancer drugs, and to better understand the biology of the role of HSP90 in the homeostasis of ERBB2. The gene discussed is ERBB2; the disease is cancer.